In vitro, ROR1-positive primary patient-derived xenografts (PDX) express higher levels of the functional stemness marker aldehyde dehydrogenase 1 (ALDH1), have a greater sphere formation efficiency, and induce tumor formation in immunodeficient mice more efficiently than ROR1-negative ovarian cancer cells [47]. This evidence concerns the gene ROR1 and ovarian carcinoma.